The blurring lines between healthcare advice and social media marketing create significant risks for medication safety and informed patient decisions. When prescription drugs enter the influencer economy, medical accuracy often becomes secondary to engagement metrics and affiliate commissions. A systematic analysis of social media prescription drug promotions reveals concerning patterns of medical misinformation embedded within influencer content. Researchers examined promotional posts across major platforms, finding consistent associations between influencer drug marketing and factually incorrect health claims. The study documented specific instances where dosing recommendations, side effect discussions, and drug interaction warnings deviated from FDA-approved labeling and clinical evidence. Most problematic were posts that minimized serious adverse effects while amplifying unsubstantiated benefits. This phenomenon represents a collision between two powerful forces: the multi-billion dollar pharmaceutical marketing apparatus and the largely unregulated influencer economy. Unlike traditional drug advertising, which faces strict FDA oversight requiring balanced risk-benefit presentations, social media promotions often escape regulatory scrutiny while reaching massive audiences. The implications extend beyond individual bad actors to systemic vulnerabilities in how medical information propagates online. Healthcare professionals increasingly report patients arriving with medication requests based on influencer recommendations rather than clinical need assessments. This research adds quantitative evidence to growing concerns about the democratization of medical advice through social platforms, where engagement algorithms may actually amplify the most misleading content due to its controversial nature.